| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HHIPL2 | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | GPX2 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | CNPY2 | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | NT5DC2 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | HPCA | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | TYR | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | SDCBP | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | VPS33B | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | GCLC | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | SPR | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
